Trial intelligence / Profile preview

Intravenous parecoxib and peripheral nerve blocks for postoperative pain after unilateral total knee arthroplasty

TCTR20191113002Phase 3Completed

Sponsor
N/A
Start
Feb 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of parecoxib in knee osteoarthritis (OA), sponsored by N/A. Started Feb 2020; status: completed.

02

Drugs

parecoxib
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on TCTR20191113002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20191113002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call